AERIS™ modernizes the traditional role of Guedel oropharyngeal airways (OPA) and nasopharyngeal airways (NPA). No longer limited to simply maintaining airway patency, OPAs and NPAs equipped with AERIS™ become state-of-the-art oxygen delivery and CO₂ monitoring systems.
With over 142 million OPAs and NPAs used annually in the U.S. alone, the time has come to transform these essential devices into solutions that elevate patient safety, streamline airway management, and reduce healthcare costs.
Finally, the AERIS Airway™ empowers anesthesia providers to surpass the American Society of Anesthesiologists (ASA) guidelines for safe and effective sedation.
Trusted by Anesthesia Providers
I predict the AERIS Airway™ becoming the standard of care when administering I.V. sedation.
—SCOTT IMUS, CRNA
ASSOCIATE PROFESSOR, MIDWESTERN UNIVERSITY
The AERIS™ administers O2 and monitors CO2 significantly better than divided nasal cannulas and face masks
—Rene M. Gonzales, MD, former Associate Prof. of Anesthesiology and Critical Care Medicine, University of Pittsburgh School of Medicine – 40 years of clinical anesthesia experience.
The AERIS Airway™ provides confidence that CO2 monitoring is within ASA guidelines and is a must-add to every anesthesiologist’s armamentarium.
—Diana Lugo, CRNA - President, Arizona Association of Nurse Anesthesiology
AERIS™ is a game changer for patient safety and monitoring ETCO2
—Eric Wardrip, MD, Medical Director, SCA Center for Surgery of Encinitas – 40 years of clinical anesthesia experience
See how the AERIS Airway™ is changing sedation. It's the future of anesthesia care.
Request a Sample
